Insight, China's Pharmaceutical Industry

Medilink Therapeutics Enters Global Licensing Agreement with BioNTech for HER3-Targeted Antibody Drug Conjugates

Suzhou-based Medilink Therapeutics has announced a strategic cooperation and global licensing agreement with Germany-headquartered BioNTech...

Company Medical Device

Jiangsu BioPerfectus Secures NMPA Approval for Norovirus Nucleic Acid Detection Kit

Fineline Cube Oct 12, 2023

China-based Jiangsu BioPerfectus Technologies Co., Ltd (SHA: 688399), a leading manufacturer of in vitro diagnostic...

Company

Kintor Pharmaceutical Secures NMPA Approval for Phase II Study of GT1708F in Idiopathic Pulmonary Fibrosis

Fineline Cube Oct 12, 2023

China-based Kintor Pharmaceutical Ltd (HKG: 9939) has announced that it has received approval from the...

Company Drug

Yiling Pharmaceutical Secures NMPA Approval for Phase I Study of G201-Na in Premenopausal Women

Fineline Cube Oct 12, 2023

China-based Yiling Pharmaceutical Co., Ltd (SHE: 002603) has announced that it has received approval from...

Company

Gritgen Therapeutics Commences Operations of Commercial GMP Facilities in Suzhou

Fineline Cube Oct 12, 2023

Suzhou-based gene therapy specialist, Gritgen Therapeutics Co., Ltd, has announced the validation completion and initiation...

Company Drug

GenFleet Therapeutics’ CDK9 Inhibitor SLS009 Earns Orphan Drug Status for AML

Fineline Cube Oct 12, 2023

Shanghai-based biotechnology company GenFleet Therapeutics has announced that its CDK9 inhibitor, SLS009 (GFH009), has received...

Company Medical Device

Cochlear’s Artificial Cochlear Sound Processor Gains NMPA Approval for Marketing in China

Fineline Cube Oct 11, 2023

Australia-based Cochlear has received marketing approval from the National Medical Products Administration (NMPA) for its...

Company Deals

Jiangsu Recbio Forms Strategic Cooperation for Vaccine Production in Zimbabwe

Fineline Cube Oct 11, 2023

China-based Jiangsu Recbio Technology Co., Ltd (HKG: 2179) has announced a tripartite strategic cooperation agreement...

Company Drug

Roche’s Forimtamig Receives Tacit Approval for Multiple Myeloma Clinical Trials

Fineline Cube Oct 11, 2023

The Center for Drug Evaluation (CDE) has indicated that Swiss pharmaceutical giant Roche (SWX: ROG)...

Company Deals

Sanofi Partners with BioMap to Accelerate AI-Driven Drug Discovery

Fineline Cube Oct 11, 2023

France-based pharmaceutical giant Sanofi (EPA: SAN) has entered into a strategic partnership with US biotech...

Company Deals

Sino Biopharmaceutical Sells 84.2% Stake in Shanghai CP General Pharmaceutical

Fineline Cube Oct 11, 2023

China-based biotech company Sino Biopharmaceutical Ltd (HKG: 1177) has announced the sale of an 84.2%...

Company Deals

Jiangsu QYuns Therapeutics Plans IPO on Hong Kong Stock Exchange

Fineline Cube Oct 11, 2023

China-based Jiangsu QYuns Therapeutics Co., Ltd (HKG: 2509) has announced its intention to pursue an...

Company Drug

Janssen Unveils Promising Clinical Data on IL-23 Blockers for Psoriasis

Fineline Cube Oct 11, 2023

The Janssen unit of Johnson & Johnson (J&J; NYSE: JNJ) is showcasing new clinical data...

Company Medical Device

MicroPort Secures Market Approvals for ULYS ICDs and INVICTA Leads in Japan

Fineline Cube Oct 11, 2023

Shanghai-based MicroPort Scientific Corp. (HKG: 0853) has announced that its France-based subsidiary, MicroPort Cardiac Rhythm...

Policy / Regulatory

Hainan Implements New Regulations for Import Drugs and Medical Devices in Medical Tourism Zone

Fineline Cube Oct 11, 2023

The Hainan Medical Products Administration, in conjunction with Hainan’s Health Commission Bureau, has unveiled a...

Company

Bayer Opens First Cell Therapy Production Facility in the U.S. to Advance Research

Fineline Cube Oct 11, 2023

Bayer AG (ETR: BAYN) has inaugurated its first production site dedicated to cell therapies, marking...

Company Drug

AstraZeneca Seeks Approval for Capivasertib in Combination with Faslodex for Breast Cancer Treatment

Fineline Cube Oct 11, 2023

AstraZeneca (AZ, NASDAQ: AZN) has submitted a market approval filing for its Category 1 drug...

Company Drug

Jiangsu Hengrui Pharmaceuticals Gets NMPA Approval for Anti-Tumor Drug Candidate SHR-2022

Fineline Cube Oct 10, 2023

Jiangsu Hengrui Pharmaceuticals Co., Ltd (SHA: 600276), a leading pharmaceutical company based in China, has...

Company Deals

China NT Pharma Group Enters MOU with Global Fund to Expand Orthopedic Product Line

Fineline Cube Oct 10, 2023

China NT Pharma Group Company Ltd (HKG: 1011), a China-based pharmaceutical company, has announced the...

Company Deals

BioCity Biopharma Partners with AstraZeneca for Phase Ib/II Study in Hepatocellular Carcinoma

Fineline Cube Oct 10, 2023

China-based biotech firm BioCity Biopharma has entered into a clinical study partnership with UK pharmaceutical...

Insight, China's Pharmaceutical Industry

Beijing QL Biopharma Files HKEX IPO Prospectus with Diversified GLP-1 Portfolio Targeting Global Obesity and Metabolic Disease Markets

China Resources Double-Crane to Acquire Nanjing Xinbai Pharma from Boya Biological for RMB 235.5 Million, Expanding Injectables Portfolio

Johnson & Johnson Acquires Atraverse Medical to Expand Cardiac Ablation Portfolio with Next-Gen Left-Heart Access Technology

Star Sports Medicine Raises HKD 830 Million in Hong Kong IPO as China’s Leading Domestic Sports Medicine Provider

Sisram Medical Forges Strategic Alliance for Daxxify Commercialization in China’s Long-Acting Botulinum Toxin Market

CSPC Pharmaceutical Receives FDA Clearance to Launch First-in-Class KAT6 Inhibitor SYH2095 Clinical Trial for Advanced Cancers

Bristol-Myers Squibb and Pfizer Partner with Mark Cuban’s Cost Plus Drugs to Offer Eliquis at $345 for 30-Day Supply, Expanding Access to Blockbuster Anticoagulant

Medilink Therapeutics Enters Global Licensing Agreement with BioNTech for HER3-Targeted Antibody Drug Conjugates

Jiangsu BioPerfectus Secures NMPA Approval for Norovirus Nucleic Acid Detection Kit

Kintor Pharmaceutical Secures NMPA Approval for Phase II Study of GT1708F in Idiopathic Pulmonary Fibrosis

Yiling Pharmaceutical Secures NMPA Approval for Phase I Study of G201-Na in Premenopausal Women

Gritgen Therapeutics Commences Operations of Commercial GMP Facilities in Suzhou

GenFleet Therapeutics’ CDK9 Inhibitor SLS009 Earns Orphan Drug Status for AML

Cochlear’s Artificial Cochlear Sound Processor Gains NMPA Approval for Marketing in China

Jiangsu Recbio Forms Strategic Cooperation for Vaccine Production in Zimbabwe

Roche’s Forimtamig Receives Tacit Approval for Multiple Myeloma Clinical Trials

Sanofi Partners with BioMap to Accelerate AI-Driven Drug Discovery

Sino Biopharmaceutical Sells 84.2% Stake in Shanghai CP General Pharmaceutical

Jiangsu QYuns Therapeutics Plans IPO on Hong Kong Stock Exchange

Janssen Unveils Promising Clinical Data on IL-23 Blockers for Psoriasis

MicroPort Secures Market Approvals for ULYS ICDs and INVICTA Leads in Japan

Hainan Implements New Regulations for Import Drugs and Medical Devices in Medical Tourism Zone

Bayer Opens First Cell Therapy Production Facility in the U.S. to Advance Research

AstraZeneca Seeks Approval for Capivasertib in Combination with Faslodex for Breast Cancer Treatment

Jiangsu Hengrui Pharmaceuticals Gets NMPA Approval for Anti-Tumor Drug Candidate SHR-2022

China NT Pharma Group Enters MOU with Global Fund to Expand Orthopedic Product Line

BioCity Biopharma Partners with AstraZeneca for Phase Ib/II Study in Hepatocellular Carcinoma

You Missed

CSPC Pharmaceutical Receives FDA Clearance to Launch First-in-Class KAT6 Inhibitor SYH2095 Clinical Trial for Advanced Cancers

Bristol-Myers Squibb and Pfizer Partner with Mark Cuban’s Cost Plus Drugs to Offer Eliquis at $345 for 30-Day Supply, Expanding Access to Blockbuster Anticoagulant

Henlius Biotech Launches Phase II/III Trial in Australia for Triple Combination Therapy in Squamous NSCLC Featuring Novel Anti-EGFR Antibody Pimurutamab and Approved PD-1 Inhibitor HanSiZhuang

Novartis Secures WHO Pre-Qualification for Coartem Baby, First Antimalarial Specifically Designed for Newborns and Infants Under 5 kg